investors hoped biogen buy smaller company focused neurosciences sage therapeutics neurocrine biosciences pressure big deal increase biogen shares closed 29 percent thursday erasing nearly $ 16 billion market value stat delivers fast deep tough minded journalism inside science labs hospitals biotech boardrooms political backrooms dissect crucial discoveries examine controversies puncture hype hold individuals institutions accountable introduce power brokers personalities driving revolution human health stories matter march 14 2019 angus chen march 4 2019 karen weintraub february 1 2019 howard m. fillit discover world changing science explore digital archive 1845 including articles 150 nobel prize winners follow scientific american arabic (c)